Zimmer Biomet (ZBH) looks undervalued: strong free cash flow, high margins, sales/EPS growth, buybacks and manageable debt.

Jack in the Box (JACK) stock update: post-Del Taco sale recovery challenges, resilient earnings, and valuation outlook. See ...

IBM's six consecutive top and bottom line double beats signal accelerating business performance. Read why IBM stock is ...

Soitec is a near-monopoly in engineered wafers, with substantial AI optionality but elevated risk at current valuation. Read ...

Chinese AI startup DeepSeek has completed a record-breaking funding round of over $7B, bringing the company's valuation to ...

Walmart’s forward P/E near 40 leaves little margin of safety; ads/membership gains remain small and growth may slow. Read ...

MF Series delivered negative absolute, but mixed relative returns. For the quarter ending December 31, 2025—actual company ...

HF Foods (HFFG) stock is downgraded to Sell amid governance turmoil, ATM overhang, margin pressure, and high leverage. See ...

Immatics is evolving into a PRAME-focused oncology platform with three monetization paths. Read why I am bullish on IMTX ...

The Touchstone Small Cap Fund underperformed its benchmark in Q1 2026 amid energy and software headwinds. Read the full ...

Northrop Grumman (NOC) rated Hold: valuation looks full despite B-21 ramp. Guidance for 2026 appears achievable. See more ...

The Virtus Zevenbergen Innovative Growth Stock Fund fell 14.67% in Q1 2026, trailing its benchmark. Read the full analysis ...